| Patents for A61K 31 - Medicinal preparations containing organic active ingredients (785,912) |
|---|
| 01/26/1995 | WO1995002419A1 Remedy for urination disorder accompanying prostatic hypertrophy |
| 01/26/1995 | WO1995002409A2 Use of vitamin d and derivatives thereof for the manufacture of a medicament for protection against neuron loss |
| 01/26/1995 | WO1995002408A1 Combination of a progestational agent and a nitric oxide synthase substrate and/or donor for the treatment of preeclampsia and preterm labor |
| 01/26/1995 | WO1995002407A1 Neuron protective and novel orotic ester |
| 01/26/1995 | WO1995002406A2 Use of benzothiophenes and benzofurans for the treatment of inflammatory bowel disease and inflammation assay method |
| 01/26/1995 | WO1995002405A1 Benzoxazinone and benzopyrimidinone piperidinyl tocolytic oxytocin receptor antagonists |
| 01/26/1995 | WO1995002404A1 Transdermal melatonin delivery system |
| 01/26/1995 | WO1995002401A1 Plaster |
| 01/26/1995 | WO1995002400A1 Taxol derivatives |
| 01/26/1995 | WO1995002399A1 Use of nabumetone or 6-methoxynaphthyl acetic acid for the treatment of dementia |
| 01/26/1995 | WO1995002398A1 Pharmaceutical composition for immunomodulating and adjuvant treatment |
| 01/26/1995 | WO1995002397A1 Self-assembling polynucleotide delivery system comprising dendrimer polycations |
| 01/26/1995 | WO1995002326A1 Solutions for tissue preservation and bloodless surgery and methods using same |
| 01/26/1995 | WO1994028014A3 Peptide inhibitors of urokinase receptor activity |
| 01/26/1995 | WO1994027589A3 Antidepressant dosage form |
| 01/26/1995 | WO1994026730A3 Novel aromatic nitro and nitroso compounds and their metabolites useful as anti-viral and anti-tumor agents |
| 01/26/1995 | DE4324877A1 Novel therapeutic mixtures, based on the prevention of intracellular Ca<2+>i overloading and Ca<2+>i independent influencing of the intracellular pHi of immunocompetent cells |
| 01/26/1995 | DE4324450A1 Pharmaceutical products containing phospholipid-nucleoside conjugates for combination therapy of viral infections |
| 01/26/1995 | DE4320878A1 Considerable improvements in immunotherapy and transplantation of bone marrow and organs |
| 01/26/1995 | CA2167409A1 Solutions for tissue preservation and bloodless surgery and methods using same |
| 01/26/1995 | CA2167391A1 Synthesis of combinatorial arrays of organic compounds through the use of multiple component combinatorial array syntheses |
| 01/26/1995 | CA2167313A1 N-(piperidinyl-1-alkyl)-substituted cyclohexane carboxylic acid amides as 5-ht1a receptor antagonists |
| 01/26/1995 | CA2167311A1 Tri-substituted imidazoles having multiple therapeutic properties |
| 01/26/1995 | CA2167287A1 Enantioselective process for thiazole intermediates |
| 01/26/1995 | CA2167201A1 Amide derivatives of 16-membered ring antibiotic macrolides |
| 01/26/1995 | CA2167194A1 Use of cephem derivatives as anti-metastatic agents |
| 01/26/1995 | CA2167169A1 Imidazo[1,2-a]pyrazin-4-one, preparation thereof and drugs containing same |
| 01/26/1995 | CA2167153A1 Prodrugs of protein tyrosine kinase inhibitors |
| 01/26/1995 | CA2167071A1 Use of coumarins and carbostyrils as pla2 inhibitors, new coumarins and carbostyrils, processes for the production thereof and pharmaceutical agents |
| 01/26/1995 | CA2167059A1 Heparin derivatives having antimetastatic activity |
| 01/26/1995 | CA2167042A1 Imidazo[4,5-c]pyridin-4-amines |
| 01/26/1995 | CA2166974A1 Substituted amide derivatives of piperizinylcamphor sulfonyl and carbonyl oxytocin antagonists |
| 01/26/1995 | CA2166873A1 Combination of a progestational agent and a nitric oxide synthase substrate and/or donor for the treatment of preeclampsia and preterm labor |
| 01/26/1995 | CA2166812A1 Agent for treating urinary outlet obstruction associated with benign prostatic hyperplasia |
| 01/26/1995 | CA2165079A1 Taxol derivatives |
| 01/26/1995 | CA2163542A1 Benzothiophenes and benzofurans as agents of therapeutic use in the treatment of inflammatory bowel disease and methods for assaying inflammation |
| 01/26/1995 | CA2162040A1 Novel vitamin d analogues |
| 01/26/1995 | CA2144518A1 Process for preparing 5,8-dihydronaphtoquinone derivatives, novel 5,8-dihydronaphtoquinone derivatives and their use as anticancer agent |
| 01/26/1995 | CA2144040A1 Defective adenovirus vectors and use thereof in gene therapy |
| 01/26/1995 | CA2143203A1 Piperazine derivatives and salts thereof |
| 01/25/1995 | EP0635509A2 Novel cephalosporin antibiotics and processes for preparation thereof |
| 01/25/1995 | EP0635507A1 Tricyclic derivatives and their use as anti-cancer agents |
| 01/25/1995 | EP0635505A1 4-Aryloxy- and 4-arylthiopiperidine derivatives |
| 01/25/1995 | EP0635501A1 Tris carbamic acid esters: inhibitors of cholesterol absorption; inhibitors of ACAT and CEH |
| 01/25/1995 | EP0635498A1 Quinazoline derivatives and their use as anti-cancer agents |
| 01/25/1995 | EP0635497A2 Benzospiroalkene derivatives, process for their preparation and pharmaceutical compostions containing them |
| 01/25/1995 | EP0635496A2 Benzospiroalkene derivatives, process for their preparation and pharmaceutical compositions containing them |
| 01/25/1995 | EP0635495A2 Benzospiroalkene derivates, process for their preparation and pharmaceutical compositions containing them |
| 01/25/1995 | EP0635492A1 Glycoprotein IIb/IIIa antagonists |
| 01/25/1995 | EP0635491A1 (Thia) cycloalkyl(b)indoles, process of their preparation and compositions containing it |
| 01/25/1995 | EP0635479A1 Perylene quinones (UCN-1028 D) derivatives |
| 01/25/1995 | EP0635270A1 Parathyroid hormone and raloxifene for increasing bone mass |
| 01/25/1995 | EP0635269A1 Use of N-(Pyridinyl)-1H-Indol-1-Amines for the preparation of a medicament for the treatment of obsessive-compulsive disorders |
| 01/25/1995 | EP0635268A1 Inhibition of phosphatidylinositol 3-kinase with wortmannin and analogs thereof |
| 01/25/1995 | EP0635267A1 Compositions containing fatty acids with antiinflammatory activity |
| 01/25/1995 | EP0635266A1 Composition comprising an omega 9 series unsaturated fatty acid in the treatment of medical symptions caused by leucotriene B4 |
| 01/25/1995 | EP0635265A1 Controlled release pharmaceutical compositions based on one or more pharmaceutically acceptable salts of gamma hydroxy-butyric acid |
| 01/25/1995 | EP0635264A2 Antiestrogens as hypoglycemic agents |
| 01/25/1995 | EP0635263A2 Angiotensin (AII) antagonists as inhibitors of the growth of adipose tissue |
| 01/25/1995 | EP0635208A1 Louse repellent compositions |
| 01/25/1995 | EP0635060A1 Myogenic vector systems |
| 01/25/1995 | EP0635026A1 Novel lipophilic oligopeptides with immunomodulating activity |
| 01/25/1995 | EP0635021A1 Process for producing derivatives of bis(aminomethyl) phosphinic acid. |
| 01/25/1995 | EP0635018A1 4-(1H-2-METHYLIMIDAZO 4,5-c]PYRIDINYLMETHYL)PHENYLSULPHONAMIDE DERIVATIVES AS ANTAGONISTS OF PAF |
| 01/25/1995 | EP0635017A1 Indole derivatives as 5-ht1 agonists |
| 01/25/1995 | EP0635008A1 Piperazides of substituted phenylalanine derivates as thrombin inhibitors |
| 01/25/1995 | EP0635007A1 Heterocyclic compounds and their use in the treatment of type ii-diabetes |
| 01/25/1995 | EP0635003A1 Perhydroisoindole derivatives as p substance antagonists |
| 01/25/1995 | EP0634996A1 1,4 naphthoquinone derivtives with anti-protozoal and anti-parasitic activity |
| 01/25/1995 | EP0634933A1 Compositions of platelet activating factor antagonists and methods of treating interleukin-2 induced lung injury therewith |
| 01/25/1995 | EP0634932A1 Method for reducing intraocular pressure in the mammalian eye by administration of muscarinic antagonists |
| 01/25/1995 | EP0634931A1 The use of quinoline-3-carboxamide compounds for treatment of diabetes |
| 01/25/1995 | EP0634930A1 Compounds useful for treating allergic and inflammatory diseases |
| 01/25/1995 | EP0634929A1 Photochemotherapeutic method using 5-aminolevulinic acid and precursors thereof |
| 01/25/1995 | EP0634928A1 Method of preparing a tablet containing s-ibuprofen |
| 01/25/1995 | EP0634927A1 Treatment and prophylaxis of diseases caused by parasites, or bacteria |
| 01/25/1995 | EP0634916A1 Method and means for preventing secondary cataract |
| 01/25/1995 | EP0634896A1 Evaluation and treatment of patients with progressive immunosuppression |
| 01/25/1995 | EP0576619B1 1,2-dithiole-3-thione derivative-based therapeutical compositions |
| 01/25/1995 | EP0558569B1 Medicaments containing sulphonamides, novel sulphonamides and proces for producing them |
| 01/25/1995 | EP0556245B1 Use of thiazolo-isoindolinone derivatives as antiviral medicaments |
| 01/25/1995 | EP0516849B1 Indole derivatives |
| 01/25/1995 | EP0480939B1 Heterocyclic amines having central nervous system activity |
| 01/25/1995 | CN1097767A Mitomycin C-dextran and its preparing method |
| 01/25/1995 | CN1097761A Polycyclic compounds and processes for the preparation thereof |
| 01/25/1995 | CN1097759A Preparation of parmaceutical compositon containing derivative of 1-pyrrolidinyl-3-chinolon and-naphthyridon carboxylic acid |
| 01/25/1995 | CN1097758A Pyrrolopyrimidines |
| 01/25/1995 | CN1097756A Heterotricyclically substituted phenyl-cyclohexane-carboxylic acid derivatives |
| 01/25/1995 | CN1097754A Process for converting loracarbef dihydrate to loracarbef monohydrate |
| 01/25/1995 | CN1097753A 5-membered heterocycles, processes for preparing them and pharmaceutical compositions containing these compounds |
| 01/25/1995 | CN1097752A Benocycloheptenes, benzoxepines and benzothiepines |
| 01/25/1995 | CN1097751A 6-fluoro quinoline keto-acid antibiotic derivative |
| 01/25/1995 | CN1097750A 5-aminoquinolone carboxylic acid derivative and antibacterial agent containing the same as active ingredient |
| 01/25/1995 | CN1097749A Benzofuranyl- and -thiopheny-alkanecarboxyclic acid derivatives |
| 01/25/1995 | CN1097746A C10 taxane derivatives and pharmaceutical compositions containing them |
| 01/25/1995 | CN1097745A 取代的哌嗪 Substituted piperazine |
| 01/25/1995 | CN1097744A Urea derivative containing heterocyclic ring |
| 01/25/1995 | CN1097743A 9H-imidazo|1,2-a¨benzimidazole-3-acetamide derivative and preparation and pharmaceuctical application of same |
| 01/25/1995 | CN1097740A Prodrugs of antiinflammatory 3-acyl-2-oxindole-1-carboxamides |
| 01/25/1995 | CN1097737A Substituted benzoylguanide preparation and pharmaceutical application of same |